Hyperphosphatemia or high phosphorus levels in the blood is one of the most common conditions during the progression of kidney disease in dogs and cats. Phosphate binders are medications used to reduce the absorption of dietary phosphate. Sevelamer carbonate is a calcium-free, aluminium-free, non-metal phosphate binder for dogs & cats. Phoslure treats hyperphosphatemia in patients with chronic kidney disease without the risk of hypercalcemia or aluminium toxicity. It significantly slows the progression of vascular calcification as compared to calcium-phosphate binders and reduces cardiovascular morbidity and mortality.

Kidney disease is a silent killer in dogs & cats. In older population, as many as 10% of dogs and 35% cats have chronic kidney disease. Kynetra is a kidney health support formula that contains proven Chinese herbs and vitamins that help to maintain and support kidney function. has potential to slow down the progression of kidney disease. Kynetra contains scientifically proven Chinese herbs, Rehmannia glutinosa, Astragalus, Cordycepsus sinensis, is indicated for AKI – Acute Kidney Injury & Chronic CKD Conditions Slows down CKD Progression Supplementation is beneficial in CKD including nephropathy secondary to diabetes, and hypertension Helps in recovery from vitamin deficiency caused by CKD Has shown potential to decrease serum creatinine, increase creatine clearance Reduce proteinuria and alleviate CKD-associated complications Helps in preventing damage to nephrons from oxidative stress caused by CKD. Improves Kidneys function by reducing excretion of proteins. Acts as reno protective.

Galibor contains the secondary bile acid, Ursodeoxy cholic acid (UDCA) and is used as an adjunctive tehrapy for patients with liver disease, particularly where cholestasis is present. Cholestasis is a condition in which the flow of bile from the liver stops or slows. Bile is a digestive fluid and the reduced flow of bile and can be caused by a liver infection, gallstones, cancer and drugs.

Sovihep 400mg Tablet contains the active component Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Sovihep 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes. Patients have generally well-tolerated with this medication, with few serious side effects reported. Sovihep 400mg Tablet should not be used in individuals with known hypersensitivity or allergic reactions to it or its components. This medication is primarily eliminated through the kidneys. Therefore, individuals with severe renal impairment may require dosage adjustments. It is not approved for use in children under the age of 18.

Viroclear 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Viroclear 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes. Patients have generally well-tolerated with this medication, with few serious side effects reported. Viroclear 400mg Tablet should not be used in individuals with known hypersensitivity or allergic reactions to it or its components. This medication is primarily eliminated through the kidneys. Therefore, individuals with severe renal impairment may require dosage adjustments. It is not approved for use in children under the age of 18.

Ketoalfa sachet contains Calcium- 3- Methyl- 2- Oxovalerate, Calcium- 4- Methyl- 2Oxovalerate, Calcium- 2- Oxo- 3- Phenylpropionate, Calcium- 3- methyl- 2- Oxobutyrate, Calcium- DL- 2- Hydroxy- 4- Butyrate, L- Lysine, L- Threonine, L- tryptophan, Histidine & Tyrosine as active ingredients. - Prevention and therapy for damages due to faulty or deficient protein metabolism in chronic renal insufficiency Key benefits/uses of Ketoalfa sachet: - Slows down CRF (Chronic Renal failure) progression rate. - Reduces unnecessary load of nitrogen and inorganic ions. - Promotes muscle protein synthesis. - Reduces pill burden and enhances compliance - Can be given to diabetic patients Direction for use/Dosage: - 40 gm per day (for adults) and less; i.e. generally in patients with a glomerular filtration rate (GFR) below 25 ml/min Indication: - Chronic Renal insufficiency Storage instructions: - Store in a cool‚ dry and dark place - Protect from the direct sunlight Safety information: - Do not exceed the daily recommended dose - Keep out of the reach and sight of children

Velasof tablet contains the active components Sofosbuvir and Velpatasvir. It is used to treat chronic hepatitis C. Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). The treatment duration is often shorter than older treatment regimens. The duration can vary depending on factors such as HCV genotype, previous treatment history, and the presence of liver cirrhosis. Successful treatment with Velasof tablet can significantly reduce liver inflammation and fibrosis caused by HCV infection. By achieving viral eradication, the risk of developing liver cirrhosis, liver failure, and hepatocellular carcinoma (a type of liver cancer) can be substantially reduced. If you have a known allergy or hypersensitivity to Velasof tablet or any of the components of the medication, you should not take it. The safety and efficacy of sofosbuvir and velpatasvir combination therapy have not been established in children under 18. Its use in the pediatric population is currently limited. It is recommended to use alternative treatment options or adjust the dosage in these cases.

Sofovir 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Sofovir 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes. Patients have generally well-tolerated with this medication, with few serious side effects reported. Sofovir 400mg Tablet should not be used in individuals with known hypersensitivity or allergic reactions to it or its components. This medication is primarily eliminated through the kidneys. Therefore, individuals with severe renal impairment may require dosage adjustments. It is not approved for use in children under the age of 18.

Mucomix 2 ML Injection is an antidote medication. It is used in the treatment of paracetamol overdose (when you may have taken too much paracetamol medicine). It protects your liver and helps to reduce the extent of the injury. Mucomix 2 ML Injection is given as an injection under the supervision of a doctor. It must be injected within 8 hours of a paracetamol overdose. It can be given up to 24 hours, but the medicine’s effectiveness slows down when given after 24 hours of the overdose. Your doctor will decide how much you need to improve your symptoms. Always follow your doctor's advice while taking this medicine. The most common side effects of this medicine include rash, urticaria, flushing, and itching. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.